MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517051542 A) filed by Zhongshan Institute For Drug Discovery, Simm, Cas; and Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences, Guangdong, China, on May 29, for 'gamma-aminobutyric acid derivative comprising polycyclic structure, method for preparing same, and use thereof.'
Inventor(s) include Zhao, Guilong; Gao, Zhaobing; Wu, Qingqing; Zheng, Yueming; Sun, Li; Tian, Fuyun; He, Jinyan; Xu, Haiyan; Chen, Yuting; Zhan, Li; Jin, Zhengsheng; Gu, Yueling; Cheng, Xinqiang; Zhang, Wenbo; and Zhang, Yuanwen.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to the field of pharmaceuticals. Specifically, the present application relates to a voltage-gated calcium ion channel a2d subunit ligand comprising a polycyclic ?-aminobutyric acid structure represented by general formula I, a method for preparing same, and use thereof in the treatment of chronic neuropathic pain, epilepsy, and anxiety."
The patent application was internationally filed on Oct. 18, 2023, under International application No.PCT/CN2023/125229.
Disclaimer: Curated by HT Syndication.
